Intavis Peptide Services

Intavis Peptide Services is a leading peptide-focused Contract Development and Manufacturing Organization (CDMO) specializing in customized peptide synthesis. With a founding date of 2019, the company has leveraged its extensive 30 years of experience in peptide synthesis to provide comprehensive services to the scientific and medical community. As a subsidiary of Intavis Instruments Corporation, the company initially focused on synthesizing peptides to validate analytical instruments. However, it later expanded its custom peptide synthesis division to capitalize on the increasing potential of peptide-based drugs in the market, collaborating with global companies and contributing to numerous research projects. Intavis Peptide Services offers a wide range of specialized services, including customized peptides for laboratory research and clinical trials, as well as consulting on peptide chemistry, medical applications, and regulatory affairs. Its dedication to reliability, effectiveness, and customer focus has earned the company an excellent reputation in the custom peptide synthesis space. The company's seasoned leadership team, with decades of experience in the biotech and life science sector, along with support from its partners, adds to its unique service offering. Based in Germany, Intavis Peptide Services serves as the go-to CDMO for researchers in biomedical research, clinicians, office-based doctors, and biotech start-ups entering the clinical stage. The company's future outlook includes the introduction of GMP-grade customized peptides specifically tailored for personalized, peptide-based medicinal products in 2024. In summary, Intavis Peptide Services stands as a reliable and innovative player within the biotechnology industry, with its focus on tailored peptide synthesis solutions catering to the evolving demands of the scientific and medical community.